Trends & Forecasts

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.

Could paper-based secondary packaging help companies be more sustainable?

From overcoming herd mentality in research to expanding cell therapy applications in cancer treatment, we explore the future of pharma.

At this time of year, we like to recognize the people and companies that have helped drive innovation and success – but we need your help.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Why we need to shift from reactive to proactive measures in tackling global health challenges.

How can pharma improve patient access to medications? Christine Marsh of Boehringer Ingelheim offers her view.

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.

An HBV gene editing clinical trial has been approved in Moldova, but the challenges go beyond science and industry.